Focus on Alternative and Complementary Therapies
www.pharmpress.com/fact
Focus Alternat Complement Ther©2005 Pharmaceutical Press
Focus Altern Complement Ther 2004; 9: 44
Gut-directed hypnotherapy (GDH) has been demonstrated to be successful in alleviating irritable bowel syndrome (IBS) symptoms within a specialist centre. This trial aimed to evaluate effectiveness in the primary care management of IBS.
To report on a recent RCT evaluating hypnotherapy in the management of IBS, highlighting issues for future CAM research.
One hundred and one patients with IBS were recruited within primary care and diagnosis was confirmed by a gastroenterologist. Eighty patients were deemed eligible for randomisation. Control patients received the usual management from their GP. Intervention patients also received five sessions of GDH. The main outcome measures were disease-specific symptoms and quality-of-life scores collected 3, 6 and 12 months post-randomisation. Qualitative data were collected from hypnotherapy patients.
Between-group comparisons demonstrate a significant difference in symptoms at 3 months, with greater pain reduction in the hypnotherapy group (32.6 vs. 46.9, P = 0.017). There was no corresponding difference in quality of life. Differences did not persist beyond 3 months. Qualitative reports from hypnotherapy patients revealed that most (81.8%, 27/33) reported definate improvement and almost all (90.9%, 30/33) stated they would recommend GDH to others. Qualitative data suggested benefits in panic reduction, enhanced feeling of symptom control and general well-being.
Conventional validated outcome measures did not demonstrate improvement in quality of life, although patients who received hypnotherapy reported this. There is a suggestion that hypnotherapy (and possibly other CAM treatments) accrue benefit in ways not detected by conventional trial outcome measures. Future studies should therefore aim to incorporate generic measures and qualitative reporting.
The hypnotherapy RCT was funded by a grant from Good Hope Hospital R&D.